PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN:1053-8569

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

PHARMACOEPIDEM DR S
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:平均3月
新锐分区:医学3区
年发文量:165
影响因子:2.4
JCR分区:Q2

基本信息

药物流行病学和药物安全的目的是为药物流行病学学科的数据、方法和观点的交流和评估提供一个国际论坛。该杂志发表原创研究的同行评审报告、特邀评论和各种客座社论和评论,涵盖药物流行病学的科学、医学、统计、法律的和经济方面以及药物安全性的上市后监测。这些类别中的适当材料也可考虑作为简要报告发表,特别关注的领域包括:研究特定药物、生物制剂或医疗器械的获益或安全性的研究的设计、分析、结果和解释,包括药物警戒、上市后监测、药物经济学、患者安全性、分子药物流行病学或药物流行病学广泛领域内的任何其他研究;与药品、生物制品和医疗器械相关的比较有效性研究。比较有效性研究是指生成和综合证据,比较预防、诊断、治疗和监测临床状况的替代方法的获益和危害,因为这些方法在真实的世界中确实使用;与药物流行病学相关的方法学贡献,无论是原创贡献、现有方法的综述,还是如何应用药物流行病学方法的指南;评估药物治疗的危害与获益;药物使用模式;药物流行病学与制定和解释监管指南之间的关系;评价与药品、生物制品和医疗器械相关的风险管理计划和方案。
1053-8569SCIE/Scopus收录
2.4
2.5
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生
3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
195/352
学科:PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
SCIE
Q2
158/421
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
194/353
学科:PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
SCIE
Q3
229/421
85
165
2%0平均3月-医学-药学
8.3%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
89.70%40.86%-
CiteScore:3.70
SJR:1.022
SNIP:0.976
学科类别分区排名百分位
大类:Medicine
小类:Epidemiology
Q2
71 / 158
大类:Medicine
小类:Pharmacology (medical)
Q3
139 / 275

期刊高被引文献

The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in Taiwan
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4713
Misuse of prescribed opioids in the United States
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4743
Ascertainment and validation of major bleeding events in a primary care database
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4580
Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended‐release long‐acting opioids
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4572
Quantifying bias reduction with fixed‐duration versus all‐available covariate assessment periods
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4729
Validating registry data on statins prescriptions by blood measurements
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4700
Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high‐risk use
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4838
Assessment of ICD‐10‐CM code assignment validity for case finding of outpatient anticoagulant‐related bleeding among Medicare beneficiaries
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4783
Adverse drug reaction reporting by community pharmacists—The barriers and facilitators
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4800
Drug‐induced anaphylactic reactions in children: A retrospective analysis of 159 validated spontaneous reports
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4726
Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4764
The importance of validating intracranial bleeding diagnoses in The Health Improvement Network, United Kingdom: Misclassification of onset and its impact on the risk associated with low‐dose aspirin therapy
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4561
Variation of the prevalence of pediatric polypharmacy: A scoping review
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4719
Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4443
Long‐term opioid therapy definitions and predictors: A systematic review
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4929
Validation of mother‐infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4843
Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4906
Does the use of incretin‐based medications increase the risk of cancer in patients with type‐2 diabetes mellitus?
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4746
The comparative effectiveness of fourth‐line drugs in resistant hypertension: An application in electronic health record data
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4808
Propensity score methods and regression adjustment for analysis of nonrandomized studies with health‐related quality of life outcomes
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4756
The double opioid crisis: A call for balance
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4720
NSAID use among residents in 68 residential aged care facilities 2014 to 2017: An analysis of duration, concomitant medication use, and high‐risk conditions
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4866
Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4883
Exposure to phthalate‐containing prescription drugs and the risk of colorectal adenocarcinoma: A Danish nationwide case‐control study
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4759
Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden: A population‐based register study
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4922
Long‐term persistence and adherence to blood pressure lowering agents among older Australians
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4742
Long‐acting opioid initiation in US nursing homes
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4568
Development and validation of a 5‐year mortality prediction model using regularized regression and Medicare data
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4769
Availability of drug at convenient stores is not associated with an increased incidence of their poisoning
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4760
Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4711
Risk of major bleeding associated with the use of direct oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: A European multicountry population-based cohort study
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/PDS.4864
Cardiovascular risks associated with dipeptidyl peptidase‐4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4847
Comparison of text processing methods in social media–based signal detection
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4857
Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4933
Implementation fidelity of patient‐centered prescription label to promote opioid safe use
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4795
Incidence, risk factors, and outcomes of warfarin‐associated major bleeding in Thai population
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4781
Capture of biologic and biosimilar dispensings in a consortium of U.S.‐based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4934
Issue Information
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4611
Developing public health tools for combating the opioid epidemic
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4871
Issue Information
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4731
Changing predictors of statin initiation in US women over two decades
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4704
Abstracts
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4732
Impact of antibiotic treatment duration on outcomes in older men with suspected urinary tract infection: Retrospective cohort study
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4791
Issue Information
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4593
Antidepressant use during pregnancy and risk of congenital heart defects: A case‐time‐control study
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4844
Use of opioids during pregnancy and effects of pregnancy outcomes
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4848
A comparison of two algorithms to identify sudden cardiac deaths in computerized databases
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4845
A survey of clarithromycin monotherapy and long‐term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims
来源期刊:Pharmacoepidemiology and Drug SafetyDOI:10.1002/pds.4951

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生
3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生
3区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生
4区